EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
We are looking for a new Chemistry curator to join the ChEBI team. Find out more about it here.
CHEBI:748603 - motrazepam
| Formula | C17H15N3O4 |
| Net Charge | 0 |
| Average Mass | 325.324 |
| Monoisotopic Mass | 325.10626 |
| SMILES | COCN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21 |
| InChI | InChI=1S/C17H15N3O4/c1-24-11-19-15-8-7-13(20(22)23)9-14(15)17(18-10-16(19)21)12-5-3-2-4-6-12/h2-9H,10-11H2,1H3 |
| InChIKey | CWCAUFWLFIUQHP-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| motrazepam (CHEBI:748603) is a benzodiazepine (CHEBI:22720) |
| INN | Source |
|---|---|
| motrazepam | WHO MedNet |
| Synonyms | Source |
|---|---|
| NSC-313451 | ChEMBL |
| Ro-06-9098 | ChEMBL |
| RO-069098 | ChEMBL |
| Citations |
|---|